Screener
Larimar Therapeutics LRMR Q2 2025 earnings
Reported August 14, 2025 · Before market open
EPS-$0.41Beat by $0.06
EPS estimate-$0.47
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.39
Versus estimates
Diluted EPS
FAQ
- When did Larimar Therapeutics report Q2 2025 earnings?
- Larimar Therapeutics (LRMR) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were Larimar Therapeutics's Q2 2025 revenue and EPS?
- Larimar Therapeutics reported eps of $-0.41 for Q2 2025.
- Did Larimar Therapeutics beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.47 by $0.06.
- How did Larimar Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 20.6% from $-0.34.
- Where can I find Larimar Therapeutics's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-108409) and the 10-Q periodic report (0000950170-25-108797) directly on SEC EDGAR. The filing index links above go to sec.gov.
